Immucor, Inc.
Reagent company announces new bank credit facility
Published in Lab Business Week, January 12th, 2004
The new credit facility matures in 3 years and is composed of a $15 million revolver and a $12 million term loan, both at terms more favorable to the company than its existing credit facility. As previously announced, the company will record a noncash, pretax charge of $924,000 in the second quarter to write off unamortized deferred financing charges related to its existing credit facility. This charge reduced second-quarter earnings by approximately $0.03 per diluted share.
Consequently, Immucor is terminating its $25.5 million secured bank line of...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Lab Business Week
Source: Lab Business Week (2004-01-12)
More Articles from Lab Business Week
- Akers Biosciences, Inc.
Biotech company announces cancellation of shares - Mayo Clinic
A rapid serological assay can identify amyloidogenic transthyretin variants - Mayo Clinic
MAPK pathway may be a potential therapeutic target in ALL - Medical University of Lodz
A whole genome screen reveals five genes associated with multiple sclerosis - Medicare
HHS secretary promotes program's changes at Wisconsin town hall meeting - Medicis
FDA approves dermal filler Restylane - More from this issue of Lab Business Week
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
